Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
1Fluart
- Development stage
- Unknown
- Lead developer
- Fluart Innovative Vaccines
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
1Fluart is an inactivated, adjuvanted whole-virus pandemic influenza vaccine developed by Fluart Innovative Vaccines. It is indicated for the active immunization and prevention of influenza infections in individuals aged 1 year and older in the event of an officially declared pandemic or pandemic threat. The vaccine is formulated with 6 µg of hemagglutinin (HA) per strain of the pandemic influenza virus (such as the H1N1 strain), in accordance with the recommendations of the World Health Organization (WHO) and the European Medicines Agency (EMA) for the current pandemic situation. It is administered as a single-dose intramuscular injection and contains aluminum phosphate gel as an adjuvant to enhance the immune response.
- Brand names
- 1Fluart
- Other names
- 1Fluart pandemic influenza vaccine1Fluart szuszpenziós injekciópandemic influenza vaccine (whole virion), inactivated, adjuvanted
02
Targets
HA (Hemagglutinin)
Beyond the preview
Go deeper on 1Fluart.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 1Fluart.